Author Title Type [ Year(Asc)]
Filters: Keyword is Mice  [Clear All Filters]
2022
Garcia WL, Miller CJ, Lomas GX, Gaither KA, Tyrrell KJ, Brandvold KR, et al.. Profiling How the Gut Microbiome Modulates Host Xenobiotic Metabolism in Response to Benzo[]pyrene and 1-Nitropyrene Exposure. Chem Res Toxicol. 2022 ;35(4):585-596.
2021
Stoddard EG, Nag S, Martin J, Tyrrell KJ, Gibbins T, Anderson KA, et al.. Exposure to an Environmental Mixture of Polycyclic Aromatic Hydrocarbons Induces Hepatic Cytochrome P450 Enzymes in Mice. Chem Res Toxicol. 2021 ;34(9):2145-2156.
2019
Stoddard EG, Killinger BJ, Nag S, Martin J, Corley RA, Wright AT. Benzo[ a]pyrene Induction of Glutathione S-Transferases: An Activity-Based Protein Profiling Investigation. Chem Res Toxicol. 2019 ;32(6):1259-1267.
Brown J, Phillips AR, Lewis DA, Mans M-A, Chang Y, Tanguay RL, et al.. Bioinformatics Resource Manager: a systems biology web tool for microRNA and omics data integration. BMC Bioinformatics. 2019 ;20(1):255.
2017
Stoddard EG, Killinger BJ, Nair RN, Sadler NC, Volk RF, Purvine SO, et al.. Activity-Based Probes for Isoenzyme- and Site-Specific Functional Characterization of Glutathione S-Transferases. J Am Chem Soc. 2017 ;139(45):16032-16035.
Madeen EP, Löhr CV, You H, Siddens LK, Krueger SK, Dashwood RH, et al.. Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice. Mol Carcinog. 2017 ;56(1):163-171.
Smith JN, Mehinagic D, Nag S, Crowell SRitger, Corley RA. In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes. Toxicol Lett. 2017 ;269:23-32.
2015
Siddens LK, Bunde KL, Harper TA, McQuistan TJ, Löhr CV, Bramer LM, et al.. Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse. Toxicol Appl Pharmacol. 2015 ;287(2):149-160.
O'Connell SG, Kerkvliet NI, Carozza S, Rohlman D, Pennington J, Anderson KA. In vivo contaminant partitioning to silicone implants: Implications for use in biomonitoring and body burden. Environ Int. 2015 ;85:182-8.
Tilton SC, Siddens LK, Krueger SK, Larkin A, Löhr CV, Williams DE, et al.. Mechanism-Based Classification of PAH Mixtures to Predict Carcinogenic Potential. Toxicol Sci. 2015 ;146(1):135-45.
Chatterjee P, Padmanarayana M, Abdullah N, Holman CL, La Du JK, Tanguay RL, et al.. Otoferlin deficiency in zebrafish results in defects in balance and hearing: rescue of the balance and hearing phenotype with full-length and truncated forms of mouse otoferlin. Mol Cell Biol. 2015 ;35(6):1043-54.
2014
Crowell SRitger, Hanson-Drury S, Williams DE, Corley RA. In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes. Toxicol Lett. 2014 ;228(1):48-55.
2013
Larkin A, Siddens LK, Krueger SK, Tilton SC, Waters KM, Williams DE, et al.. Application of a fuzzy neural network model in predicting polycyclic aromatic hydrocarbon-mediated perturbations of the Cyp1b1 transcriptional regulatory network in mouse skin. Toxicol Appl Pharmacol. 2013 ;267(2):192-9.
Shorey LE, Madeen EP, Atwell LL, Ho E, Löhr CV, Pereira CB, et al.. Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane. Toxicol Appl Pharmacol. 2013 ;270(1):60-9.
Crowell SRitger, Sharma AK, Amin SG, Soelberg JJ, Sadler NC, Wright AT, et al.. Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice. Toxicol Sci. 2013 ;135(1):48-62.
2012
Siddens LK, Larkin A, Krueger SK, Bradfield CA, Waters KM, Tilton SC, et al.. Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol Appl Pharmacol. 2012 ;264(3):377-86.
Shorey LE, Castro DJ, Baird WM, Siddens LK, Löhr CV, Matzke MM, et al.. Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring. Cancer Lett. 2012 ;317(1):49-55.
2011
Crowell SRitger, Amin SG, Anderson KA, Krishnegowda G, Sharma AK, Soelberg JJ, et al.. Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents. Toxicol Appl Pharmacol. 2011 ;257(3):365-76.
2010
O'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, et al.. The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One. 2010 ;5(10).
2009
Bisson WH, Koch DC, O'Donnell EF, Khalil SM, Kerkvliet NI, Tanguay RL, et al.. Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands. J Med Chem. 2009 ;52(18):5635-41.
2006
Yu Z, Löhr CV, Fischer KA, Louderback MA, Krueger SK, Dashwood RH, et al.. In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res. 2006 ;66(2):755-62.